|
|
Prosthetic Joint Infection After Primary Total Knee Arthroplasty: Incidence, Microbiology and Risk Factors |
| 1F32AI164809-01A1 |
|
NIAID |
2022 |
|
|
Regulation of memory CD8 T cell development |
| 3R37AI066232-18S1 |
|
NIAID |
2022 |
|
|
Macrophage mitochodrial reprogramming and innate immune memory |
| 5R01AI151210-03 |
|
NIAID |
2022 |
|
|
The effects of BTNL2 on experimental autoimmune encephalomyelitis |
| 5R21AI156779-02 |
|
NIAID |
2022 |
|
|
A New Approach to Treat Prosthetic Joint Infections with a ClpP Activating Antibiotic |
| 5R44AI157081-02 |
|
NIAID |
2022 |
|
|
Mechanisms of GM-CSF effect in CNS autoimmune demyelination |
| 5 R01 AI124386-14 |
ROSTAMI, AM |
NIAID |
2021 |
|
|
Linking diet, gut microbiota and autoimmune disease: Bacteria induced phytoestrogen metabolites impact immune function in Experimental Autoimmune Encephalitis |
| 5 R01 AI137075-04 |
MANGALAM, ASHUTOSH KUMAR |
NIAID |
2021 |
|
|
Defining the Role of Molecules Unique to Encephalitogenic T Cells in MS |
| 5 R01 AI140741-03 |
LOVETT-RACKE, AMY E |
NIAID |
2021 |
|
|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
| 5 R01 AI148178-02 |
SCHWAB, SUSAN RUTH |
NIAID |
2021 |
|
|
HIV-1 Tat genetic variation impacts NeuroAIDS |
| 2R01NS089435-06 |
NONNEMACHER, MICHAEL R |
NIAID |
2020 |
